These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29229491)

  • 1. Could cannabis liberalisation lead to wider changes in drug policies and outcomes?
    Hughes B; Wiessing L; Des Jarlais D; Griffiths P
    Int J Drug Policy; 2018 Jan; 51():156-159. PubMed ID: 29229491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of drug policy liberalisation on willingness to seek help for problem drug use: A comparison of 20 countries.
    Benfer I; Zahnow R; Barratt MJ; Maier L; Winstock A; Ferris J
    Int J Drug Policy; 2018 Jun; 56():162-175. PubMed ID: 29731288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic analysis of different cannabis decriminalization scenarios.
    Ogrodnik M; Kopp P; Bongaerts X; Tecco JM
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S309-14. PubMed ID: 26417786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problematic substance use or problematic substance use policies?
    Stockwell T; Benoit C; Card K; Sherk A
    Health Promot Chronic Dis Prev Can; 2020 Jun; 40(5-6):135-142. PubMed ID: 32529972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice.
    Lucas P
    Int J Drug Policy; 2009 Jul; 20(4):296-303. PubMed ID: 19124233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Should I Buy or Should I Grow?" How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic.
    Belackova V; Maalsté N; Zabransky T; Grund JP
    Int J Drug Policy; 2015 Mar; 26(3):296-310. PubMed ID: 25655217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis policy reforms in the Americas: a comparative analysis of Colorado, Washington, and Uruguay.
    Pardo B
    Int J Drug Policy; 2014 Jul; 25(4):727-35. PubMed ID: 24970383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new front in the war on doping: Amateur athletes.
    Henning AD; Dimeo P
    Int J Drug Policy; 2018 Jan; 51():128-136. PubMed ID: 28619395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-medical cannabis use: international policies and outcomes overview. An outline for Portugal.
    Barata PC; Ferreira F; Oliveira C
    Trends Psychiatry Psychother; 2022 May; 44(Suppl 1):e20210239. PubMed ID: 34898143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding to the cannabis debate: Comment on various Central Drug Authority papers.
    Scott K
    S Afr Med J; 2016 Aug; 106(9):838-9. PubMed ID: 27601102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two steps forward, one step back: current harm reduction policy and politics in the United States.
    Nadelmann E; LaSalle L
    Harm Reduct J; 2017 Jun; 14(1):37. PubMed ID: 28606093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kind of peace: Tracking the reflexive and resilient drug war.
    McLean K
    Int J Drug Policy; 2018 Jan; 51():117-120. PubMed ID: 29249299
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug policy reform and the reclassification of cannabis in England and Wales: A cautionary tale.
    Shiner M
    Int J Drug Policy; 2015 Jul; 26(7):696-704. PubMed ID: 25959525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding post 9/11 drug control policy and politics in Central Asia.
    Latypov A
    Int J Drug Policy; 2009 Sep; 20(5):387-91. PubMed ID: 19121928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dawning demand for a new cannabis policy: A study of Swedish online drug discussions.
    Månsson J
    Int J Drug Policy; 2014 Jul; 25(4):673-81. PubMed ID: 24794114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis.
    Melchior M; Nakamura A; Bolze C; Hausfater F; El Khoury F; Mary-Krause M; Azevedo Da Silva M
    BMJ Open; 2019 Jul; 9(7):e025880. PubMed ID: 31296507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cannabis decriminalisation in Australia and the United States.
    Single E; Christie P; Ali R
    J Public Health Policy; 2000; 21(2):157-86. PubMed ID: 10881453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulating a novel drug: an evaluation of changes in use of Salvia divinorum in the first year of Florida's ban.
    Stogner J; Khey DN; Griffin OH; Miller BL; Boman JH
    Int J Drug Policy; 2012 Nov; 23(6):512-21. PubMed ID: 22502947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenges in developing a rational cannabis policy.
    Hall W; Lynskey M
    Curr Opin Psychiatry; 2009 May; 22(3):258-62. PubMed ID: 19293714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV, injecting drug use and harm reduction: a public health response.
    Ball AL
    Addiction; 2007 May; 102(5):684-90. PubMed ID: 17506148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.